68 related articles for article (PubMed ID: 12892738)
1. Low frequency of anti-SLA/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay.
Miyakawa H; Kawashima Y; Kitazawa E; Kawaguchi N; Kato T; Kikuchi K; Imai E; Fujikawa H; Hashimoto E; Schlumberger W
J Autoimmun; 2003 Aug; 21(1):77-82. PubMed ID: 12892738
[TBL] [Abstract][Full Text] [Related]
2. The frequency and clinical significance of antibodies to soluble liver antigen/liver pancreas in autoimmune hepatitis: a prospective single-center study.
Yüksekyayla O; Kina N; Ulaba A; Emin Ergün M; Batibay E; Şimşek C; Yildiz Zeyrek F; Wahlin S; Efe C
Eur J Gastroenterol Hepatol; 2024 May; 36(5):652-656. PubMed ID: 38477840
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies and autoantigens in autoimmune hepatitis: important tools in clinical practice and to study pathogenesis of the disease.
Zachou K; Rigopoulou E; Dalekos GN
J Autoimmune Dis; 2004 Oct; 1(1):2. PubMed ID: 15679907
[TBL] [Abstract][Full Text] [Related]
4. Structural mimicry between SLA/LP and Rickettsia surface antigens as a driver of autoimmune hepatitis: insights from an in silico study.
Paiardini A; Pascarella S
Theor Biol Med Model; 2013 Apr; 10():25. PubMed ID: 23575112
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune hepatitis-specific antibodies against soluble liver antigen and liver cytosol type 1 in patients with chronic viral hepatitis.
Rigopoulou EI; Mytilinaiou M; Romanidou O; Liaskos C; Dalekos GN
J Autoimmune Dis; 2007 Feb; 4():2. PubMed ID: 17274827
[TBL] [Abstract][Full Text] [Related]
6. Novel autoantibody targets identified in patients with autoimmune hepatitis (AIH) by PhIP-Seq reveals pathogenic insights.
Klepper A; Kung A; Vazquez SE; Mitchell A; Mann S; Zorn K; Avila-Vargas I; Kari S; Tekeste M; Castro J; Lee B; Duarte M; Khalili M; Yang M; Wolters P; Price J; Perito E; Feng S; Maher JJ; Lai J; Weiler-Normann C; Lohse AW; DeRisi J; Tana M
medRxiv; 2023 Jun; ():. PubMed ID: 37398174
[TBL] [Abstract][Full Text] [Related]
7. Exploratory Study of Autoantibody Profiling in Drug-Induced Liver Injury with an Autoimmune Phenotype.
Lammert C; Zhu C; Lian Y; Raman I; Eckert G; Li QZ; Chalasani N
Hepatol Commun; 2020 Nov; 4(11):1651-1663. PubMed ID: 33163835
[TBL] [Abstract][Full Text] [Related]
8. Accepting clocks that tell time poorly: fluid-phase versus standard ELISA autoantibody assays.
Liu E; Eisenbarth GS
Clin Immunol; 2007 Nov; 125(2):120-6. PubMed ID: 17904423
[TBL] [Abstract][Full Text] [Related]
9. Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity.
Roggenbuck D; Mytilinaiou MG; Lapin SV; Reinhold D; Conrad K
Auto Immun Highlights; 2012 Dec; 3(3):119-25. PubMed ID: 26000135
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody Profiling Using Human Autoantigen Protein Array and AlphaScreen.
Takeda H
Methods Mol Biol; 2024; 2766():107-128. PubMed ID: 38270871
[TBL] [Abstract][Full Text] [Related]
11. Clinical Performance of the Line Immunoassay and Digital Liquid Chip Method for Detecting Autoimmune Liver Disease Autoantibodies.
Lv H; Deng A; Chen Y; Su Z
Arch Pathol Lab Med; 2024 Jun; ():. PubMed ID: 38830630
[TBL] [Abstract][Full Text] [Related]
12. Decoding the autoantibody reactome.
Jaycox JR; Dai Y; Ring AM
Science; 2024 Feb; 383(6684):705-707. PubMed ID: 38359108
[TBL] [Abstract][Full Text] [Related]
13. CD74 auto-antibodies display little clinical value in Chinese Han population with axial spondyloarthritis.
Hu CJ; Li MT; Li X; Peng LY; Zhang SZ; Leng XM; Su JM; Zeng XF
Medicine (Baltimore); 2020 Dec; 99(50):e23433. PubMed ID: 33327271
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis: diagnostic accuracy of antinuclear antibodies, smooth muscle antibodies and antibodies to a soluble liver antigen/liver pancreas in autoimmune hepatitis.
Zhang WC; Zhao FR; Chen J; Chen WX
PLoS One; 2014; 9(3):e92267. PubMed ID: 24651126
[TBL] [Abstract][Full Text] [Related]
15. Development of a recombinant cell-based indirect immunofluorescence assay for the determination of autoantibodies against soluble liver antigen in autoimmune hepatitis.
Radzimski C; Probst C; Teegen B; Rentzsch K; Blöcker IM; Dähnrich C; Schlumberger W; Stöcker W; Bogdanos DP; Komorowski L
Clin Dev Immunol; 2013; 2013():572815. PubMed ID: 23401700
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune hepatitis as a unique form of an autoimmune liver disease: immunological aspects and clinical overview.
Fallatah HI; Akbar HO
Autoimmune Dis; 2012; 2012():312817. PubMed ID: 23304455
[TBL] [Abstract][Full Text] [Related]
17. Advances in the current treatment of autoimmune hepatitis.
Czaja AJ
Dig Dis Sci; 2012 Aug; 57(8):1996-2010. PubMed ID: 22476586
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of autoimmune liver disease related autoantibodies in Chinese patients with primary biliary cirrhosis.
Hu C; Deng C; Song G; Zhang W; Zhang S; Li X; Li P; Zhang F; Li Y
Dig Dis Sci; 2011 Nov; 56(11):3357-63. PubMed ID: 21660486
[TBL] [Abstract][Full Text] [Related]
19. Study of nonstandard auto-antibodies as prognostic markers in auto immune hepatitis in children.
El-Din Elshazly LB; Youssef AM; Mahmoud NH; Ibrahim MM
Ital J Pediatr; 2009 Jul; 35(1):22. PubMed ID: 19712439
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies in primary sclerosing cholangitis.
Hov JR; Boberg KM; Karlsen TH
World J Gastroenterol; 2008 Jun; 14(24):3781-91. PubMed ID: 18609700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
